|
ConvaTec Group PLC - London-based medical products - Starts on Wednesday a share buyback worth up to $300 million. The buyback will be run by UBS AG and will be completed by the end of December, though ConvaTec says it could be extended. Some repurchased shares will be held in Treasury for employee share plans, with the rest cancelled. ConvaTec says the buyback is being launched after it confirmed its 2025 guidance in its half-year results last month. Current stock price: 244.40 pence, up 5.7% in London on Wednesday 12-month change: up 4.4% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
